Excellent and entertaining debate at #TTLC25 on the best 1L therapy for EGFR NSCLC by Drs Helena Yu and Shirish Gadgeel

Multiple considerations including baseline factors and patient centered shared decision making whether to add chemo to osimertinib

#lcsm #oncsky @iaslc.bsky.social